Advanced Search


Study ID Status Title Patient Level Data
110886 Completed Immunogenicity and safety study of GSK Biologicals' HPV vaccine (GSK-580299) co-administered with a commercially available vaccine in healthy female adolescents Study Listed on
110927 Completed A Single Arm, Safety and Efficacy Study of Ofatumumab in Combination with ICE or DHAP Chemotherapy in Relapsed or Refractory Aggressive Lymphoma Prior to Autologous Stem Cell Transplantation
110932 Completed A Dose Finding Study of GSK716155 versus Placebo in the Treatment of Type 2 Diabetes Mellitus Study Listed on
110946 Completed A three-way incomplete block crossover study to investigate the 24-hour pulmonary function of three dosage strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder vs. Placebo, in subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on
110947 Completed Evaluation of GSK Biological’s dTpa-IPV booster vaccine in children and adolescents, 5 years after previous dTpa-IPV boosting. Study Listed on
110948 Completed Assessment of the effect of sumatriptan and naproxen sodium combination tablet, sumatriptan tablet, and naproxen sodium tablet treatment on blood pressure when administered intermittently for six months for the acute treatment of migraine attacks, with or without aura, in adults Study Listed on
110951 Completed A two-part, randomised, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamicsof single and repeat doses of intravenously infused GSK1995057 in healthy subjects. Study Listed on
110978 Completed A Randomized, Double-Blind, Double Dummy, Comparative, Multicenter Study to Assess the Safety and Efficacy of Topical Retapamulin Ointment, 1%, versus Oral Linezolid in the Treatment of Secondarily-Infected Traumatic Lesions and Impetigo Due to Methicillin-Resistant Staphylococcus aureus Study Listed on
111109 Completed An open-label, multicenter, phase I/II study of pazopanib in combination with paclitaxel in first-line treatment of subjects with stage IIIBwet/IV non-small cell lung cancer
111114 Completed A Randomized, Double-Blind, Parallel-Group, 24-Week Study to Evaluate the Efficacy and Safety of ADVAIR DISKUS (Fluticasone Propionate/Salmeterol Combination Product 250/50mcg Inhalation Powder) BID Plus Spiriva HandiHaler (Tiotropium Bromide Inhalation Powder 18mcg) QD Versus Spiriva QD Plus Placebo DISKUS BID in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on
111116 Completed Prevalence of Chronic Airway Onstruction in a Subject Population with a History of Cigarette Smoking in a Primary care Setting
111117 Completed A Randomized, Double-Blind, Double-Dummy, Parallel Group 12-Week Comparison of the Efficacy and Safety of Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a Metered-Dose-Inhaler 230/42mcg twice-daily with Fluticasone Propionate/Salmeterol DISKUS 250/50mcg twice-daily in subjects with COPD Study Listed on
111128 Completed An open-label, multicentre, randomised phase II study of pazopanib in combination with pemetrexed in first-line treatment of subjects with predominantly non-squamous cell stage IIIB wet/IV non-small cell lung cancer
111149 Completed Evaluate the effect of risk factors that influence the immunogenicity of GSK Biologicals' Twinrix compared to hepatitis A and hepatitis B vaccines given separately and to show the non-inferiority between the vaccines in adults Study Listed on
111155 Completed A double blind, parallel group, placebo controlled study to evaluate the effect of a single oral dose of GSK958108 on ejaculatory latency time (ELT) in male patient suffering from premature ejaculation Study Listed on
111157 Completed Immunogenicity and safety study of GlaxoSmithKline Biologicals’ Infanrix hexa™ vaccine in healthy infants in India Study Listed on
111188 Completed Primary vaccination course in healthy children receiving the pneumococcal vaccine GSK 1024850A co-administered with Tritanrix™-HepB/Hib at 6, 10 and 14 weeks of age Study Listed on
111192 Completed Retrospective Study of Asthma-Related Healthcare Utilization and Costs in Patients with Asthma Receiving Early versus Late Treatment with Fluticasone Propionate/Salmeterol Combination
111194 Completed Advair vs. ICS+Singulair Outcomes Study in Pediatric Patients with Asthma
111258 Completed Observer-blind, Post-Marketing Study to Compare the Safety and Immunogenicity of Fluviral® Trivalent Split Virion Influenza Vaccine (2007-2008 Season) Made With New vs. Aged Bulk Material, in Adults Ranging in Age from 18 to 60 Years Study Listed on
111266 Completed Impact of initiating tiotropium alone versus initiating tiotropium in combination with fluticasone propionate/salmeterol xinafoate combination (FSC) on Chronic Obstructive Pulmonary Disease-related outcomes in patients with pre-existing exacerbations
111295 Completed Immunogenicity and safety study of a GSK influenza vaccine candidate GSK 2115160A in adults. Study Listed on
111314 Completed A First-Time-In-Human, Three-Part, Placebo-Controlled, Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1521498 in Healthy Subjects Study Listed on
111319 Terminated A Single-Blind, Placebo-Controlled, Randomized First Time in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Dose Escalation of GSK932121 in Healthy Adult Subjects Study Listed on
111341 Completed A Double-Blind, Parallel, Randomized, Placebo-Controlled, Single Dose Escalation First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Investigational Study Drug in Healthy Subjects Study Listed on



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.